Collegium Pharmaceutical Inc (COLL)
33.55
+0.09
(+0.27%)
USD |
NASDAQ |
Nov 04, 13:04
Collegium Pharmaceutical Total Liabilities (Quarterly): 836.80M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 836.80M |
| March 31, 2024 | 892.08M |
| December 31, 2023 | 947.88M |
| September 30, 2023 | 998.70M |
| June 30, 2023 | 1.013B |
| March 31, 2023 | 1.035B |
| December 31, 2022 | 979.29M |
| September 30, 2022 | 1.004B |
| June 30, 2022 | 1.048B |
| March 31, 2022 | 1.050B |
| December 31, 2021 | 489.15M |
| September 30, 2021 | 490.71M |
| June 30, 2021 | 460.67M |
| March 31, 2021 | 476.03M |
| December 31, 2020 | 457.81M |
| September 30, 2020 | 471.16M |
| June 30, 2020 | 491.10M |
| March 31, 2020 | 493.73M |
| December 31, 2019 | 218.87M |
| September 30, 2019 | 219.72M |
| Date | Value |
|---|---|
| June 30, 2019 | 215.76M |
| March 31, 2019 | 208.01M |
| December 31, 2018 | 199.66M |
| September 30, 2018 | 575.73M |
| June 30, 2018 | 590.65M |
| March 31, 2018 | 605.46M |
| December 31, 2017 | 31.49M |
| September 30, 2017 | 26.40M |
| June 30, 2017 | 29.00M |
| March 31, 2017 | 25.48M |
| December 31, 2016 | 27.11M |
| September 30, 2016 | 24.40M |
| June 30, 2016 | 21.07M |
| March 31, 2016 | 14.61M |
| December 31, 2015 | 12.65M |
| September 30, 2015 | 13.49M |
| June 30, 2015 | 11.76M |
| March 31, 2015 | 12.95M |
| December 31, 2014 | 17.33M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
218.87M
Minimum
Dec 2019
1.050B
Maximum
Mar 2022
729.13M
Average
836.80M
Median
Jun 2024
Total Liabilities (Quarterly) Benchmarks
| Rigel Pharmaceuticals Inc | 158.32M |
| Esperion Therapeutics Inc | 696.54M |
| Context Therapeutics Inc | 1.604M |
| NovaBay Pharmaceuticals Inc | 4.542M |
| Palatin Technologies Inc | 10.85M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.053B |
| Shareholders Equity (Quarterly) | 216.58M |
| Debt to Equity Ratio | 2.552 |
| Current Ratio | 1.105 |
| Net Debt Paydown Yield | 4.72% |